b3c newswire, the first PR distribution service specializing in press release dissemination for the biotech industry, announces that it has the largest reach in biotech and pharmaceutical trade magazines worldwide.
With more than 1,500 media titles and many specialized channels b3c newswire assures an excellent visibility of press releases in print and the Internet. Currently, b3c has established 15 specialized channels to micro-target news. Specialized channels include Biomanufacturing, Oncology, Nanotechnology, Food & Nutrition, Medical Devices & Diagnostics, Clinical Trials, Pain, Cardiology, Neuroscience, Bio-IT, Imaging, Stem Cells, Chemistry, Lab Automation and Hospitals & Doctors. b3c newswire also pro-actively posts press releases with targeted biotech social media sites to optimize B2B communications.
Most PR distribution companies serve hundreds of industries and biotech is only one of many. As a result of the suboptimal distribution lists a lot of biotech companies still invest a lot of time and money to maintain their own trade media lists in addition to using wire services.
“Smaller biotech companies, who have only a few press releases per year, lack the time and internal resources to establish and maintain own trade media lists. With b3c newswire biotech companies (b3cnewswire.com) now have access to up-to-date media contacts whenever they need them,” says Sabine Duntze from b3c newswire.
b3c’s experts are experienced biotech PR consultants with a life science background. All media titles are hand-picked during many years in business and the distribution network is continuously developed to ensure its consistent high quality and reach.